Hepatitis A virus infection
Hepatitis A is a vaccine-preventable infection caused by the hepatitis A virus (HAV). Over
150 million new infections of hepatitis A occur annually. HAV causes an acute inflammatory …
150 million new infections of hepatitis A occur annually. HAV causes an acute inflammatory …
[HTML][HTML] Viral Hepatitis in pregnancy
VN Chilaka, JC Konje - European Journal of Obstetrics & Gynecology and …, 2021 - Elsevier
The global prevalence of viral hepatitis is very high and seems to be rising over the years.
The infection can profoundly affect pregnant women causing significant maternal and …
The infection can profoundly affect pregnant women causing significant maternal and …
EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy
Liver diseases in pregnancy comprise both gestational liver disorders and acute and chronic
hepatic disorders occurring coincidentally in pregnancy. Whether related to pregnancy or …
hepatic disorders occurring coincidentally in pregnancy. Whether related to pregnancy or …
Risk factors and prevention of viral hepatitis-related hepatocellular carcinoma
X Zhang, L Guan, H Tian, Z Zeng, J Chen… - Frontiers in …, 2021 - frontiersin.org
Hepatocellular carcinoma (HCC) is a common cancer in the world, and its incidence is
increasing yearly. Hepatitis B virus (HBV) infection and hepatitis C virus (HCV) infection are …
increasing yearly. Hepatitis B virus (HBV) infection and hepatitis C virus (HCV) infection are …
Burden of chronic hepatitis B and C infections in 2015 and future trends in Japan: a simulation study
J Tanaka, A Kurisu, M Ohara, S Ouoba… - The Lancet Regional …, 2022 - thelancet.com
Background Determining the number of chronic hepatitis B (HBV) and C virus (HCV)
infections is essential to assess the progress towards the World Health Organization 2030 …
infections is essential to assess the progress towards the World Health Organization 2030 …
The role of red cell distribution width as a prognostic marker in chronic liver disease: a literature review
H Aslam, F Oza, K Ahmed, J Kopel… - International Journal of …, 2023 - mdpi.com
Liver disease is one of the leading public health problems faced by healthcare practitioners
regularly. As such, there has been a search for an inexpensive, readily available, non …
regularly. As such, there has been a search for an inexpensive, readily available, non …
The mechanism of ferroptosis and its related diseases
S Feng, D Tang, Y Wang, X Li, H Bao, C Tang… - Molecular …, 2023 - Springer
Ferroptosis, a regulated form of cellular death characterized by the iron-mediated
accumulation of lipid peroxides, provides a novel avenue for delving into the intersection of …
accumulation of lipid peroxides, provides a novel avenue for delving into the intersection of …
[HTML][HTML] Innate and adaptive immune escape mechanisms of hepatitis B virus
HJ Zhao, YF Hu, QJ Han, J Zhang - World Journal of …, 2022 - ncbi.nlm.nih.gov
Chronic hepatitis B virus (HBV) infection is an international health problem with extremely
high mortality and morbidity rates. Although current clinical chronic hepatitis B (CHB) …
high mortality and morbidity rates. Although current clinical chronic hepatitis B (CHB) …
Safety and efficacy of tenofovir alafenamide fumarate in early-middle pregnancy for mothers with chronic hepatitis B
R Chen, J Zou, L Long, H Huang, M Zhang… - Frontiers in …, 2022 - frontiersin.org
Background Tenofovir alafenamide fumarate has been used in late pregnancy; however, no
data exist regarding its safety and effectiveness in early and middle pregnancy for mothers …
data exist regarding its safety and effectiveness in early and middle pregnancy for mothers …
Spectroscopic study to verify the anti-hepatitis C virus (HCV) treatment through a delivery system of the sofosbuvir drug on chitosan and pycnogenol nanoparticles …
NM El-Shafai, AI Nada, MA Farrag, K Alatawi… - … Acta Part A: Molecular …, 2023 - Elsevier
The target of the current study is to create a novel hybrid nanocomposite (Cs@ Pyc. SOF) by
combining the anti-hepatitis C virus (HCV) drug sofosbuvir with the nano antioxidant …
combining the anti-hepatitis C virus (HCV) drug sofosbuvir with the nano antioxidant …